What does this research mean for the field?

A newly synthesized thiazole derivative, compound 4j, acts as a potent and selective EGFR inhibitor that effectively induces apoptosis and suppresses proliferation in human colon cancer cells. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To synthesize novel thiazole derivatives designed as EGFR inhibitors and assess their anticancer efficacy against human colon cancer cell lines.

September 3, 2026Future Medicinal Chemistry

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies

View Full Paper

Ask AI

Bookmark

To synthesize novel thiazole derivatives designed as EGFR inhibitors and assess their anticancer efficacy against human colon cancer cell lines.
Synthesized a series of novel thiazole derivatives through rational drug design.
Evaluated antiproliferative activity against human colon cancer cell lines (HCT-116 and HT29) and normal fibroblasts (WI38), followed by in vitro EGFR kinase inhibition assays.
Conducted apoptosis assays assessing Bax, Bcl-2, and p53 modulation, along with computational molecular docking and ADME pharmacokinetic profiling.
Lead compound 4j showed the strongest antiproliferative effects, with IC50 values of 2.10 µM in HCT-116 cells and 1.91 µM in HT29 cells.
Compound 4j potently inhibited the EGFR kinase domain with an IC50 of 0.27 µM while maintaining selective safety toward normal WI38 cells.
Apoptosis induction occurred through altered expression of Bax, Bcl-2, and p53, supported by stable binding in the EGFR active site and favorable predicted drug-like ADME properties.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

In vitro and in silico study demonstrates potent colon cancer inhibition by a novel thiazole derivative, indicating its therapeutic potential as an EGFR-targeted antitumor agent.

Cite This Study

Alsaedi et al. (2026) studied this question.

synapsesocial.com/papers/6a99351f636c6408cfa7cffa https://doi.org/10.1080/17568919.2026.2726191

View Full Paper

Ask AI

Bookmark

Implication

In vitro and in silico study demonstrates potent colon cancer inhibition by a novel thiazole derivative, indicating its therapeutic potential as an EGFR-targeted antitumor agent.

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies

Key Points

Discussion

Implication

Cite This Study

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider